Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ann C. Childress. (2016) Methylphenidate HCL for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy 17:8, pages 1171-1178.
Read now
Read now
Josephine Elia, Zoe Wilson, Lilly Sehgal La Porta, Sibel A Algon, Matthew L Prowler, Shanique T Cartwright, Patricia A McKenna, Seth Laracy, Toshinobu Takeda & Karin Borgmann-Winter. (2011) Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder. Expert Review of Clinical Pharmacology 4:3, pages 311-328.
Read now
Read now
Articles from other publishers (19)
Ole Jakob Storebø, Maja Rosenberg Overby Storm, Johanne Pereira Ribeiro, Maria Skoog, Camilla Groth, Henriette E Callesen, Julie Perrine Schaug, Pernille Darling Rasmussen, Christel-Mie L Huus, Morris Zwi, Richard Kirubakaran, Erik Simonsen & Christian Gluud. (2023) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews 2023:3.
Crossref
Crossref
Christoph U. Correll, Brittney R. Starling & Michael Huss. (2021) Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients. CNS Spectrums, pages 1-13.
Crossref
Crossref
Ole Jakob Storebø, Nadia Pedersen, Erica Ramstad, Maja Laerke Kielsholm, Signe Sofie Nielsen, Helle B Krogh, Carlos R Moreira-Maia, Frederik L Magnusson, Mathilde Holmskov, Trine Gerner, Maria Skoog, Susanne Rosendal, Camilla Groth, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Sasja J Håkonsen, Lise Aagaard, Erik Simonsen & Christian Gluud. (2018) Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews.
Crossref
Crossref
David R. Coghill, Tobias Banaschewski, César Soutullo, Matthew G. Cottingham & Alessandro Zuddas. (2017) Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry 26:11, pages 1283-1307.
Crossref
Crossref
Louis S. Matza, Mary Kay Margolis, Linda S. Deal, Kimberly F. Farrand & M. Haim Erder. (2017) Challenges of Developing an Observable Parent-Reported Measure: A Qualitative Study of Functional Impact of ADHD in Children. Value in Health 20:6, pages 828-833.
Crossref
Crossref
Ole Jakob Storebø, Erica Ramstad, Helle B. Krogh, Trine Danvad Nilausen, Maria Skoog, Mathilde Holmskov, Susanne Rosendal, Camilla Groth, Frederik L Magnusson, Carlos R Moreira-Maia, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Bente Forsbøl, Erik Simonsen & Christian Gluud. (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Systematic Reviews 2016:11.
Crossref
Crossref
Stephanie G. Craig, Gregory Davies, Larry Schibuk, Margaret D. Weiss & Lily Hechtman. (2015) Long-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients?. Current Developmental Disorders Reports 2:1, pages 1-9.
Crossref
Crossref
Anthony Rostain, Peter S. Jensen, Daniel F. Connor, Laura M. Miesle & Stephen V. Faraone. (2013) Toward Quality Care in ADHD. Journal of Attention Disorders 19:2, pages 99-117.
Crossref
Crossref
Robert L. Findling & Steven Dinh. (2014) Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS). CNS Drugs 28:3, pages 217-228.
Crossref
Crossref
Alon Avisar & Maya Lavie-Ajayi. (2014) The Burden of Treatment: Listening to Stories of Adolescents With ADHD About Stimulant Medication Use. Ethical Human Psychology and Psychiatry 16:1, pages 37-50.
Crossref
Crossref
Sunil Karande. 2012. Handbook of Children with Special Health Care Needs. Handbook of Children with Special Health Care Needs
73
85
.
Andrew Lloyd, Paul Hodgkins, Rahul Sasane, Ron Akehurst, Edmund J.S. Sonuga-Barke, Patrick Fitzgerald, Annabel Nixon, Haim Erder & John Brazier. (2011) Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations. The Patient: Patient-Centered Outcomes Research 4:4, pages 247-257.
Crossref
Crossref
Kevin M Antshel, Teresa M Hargrave, Mihai Simonescu, Prashant Kaul, Kaitlin Hendricks & Stephen V Faraone. (2011) Advances in understanding and treating ADHD. BMC Medicine 9:1.
Crossref
Crossref
Aribert Rothenberger, Andreas Becker, Dieter Breuer & Manfred Döpfner. (2011) An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence. European Child & Adolescent Psychiatry 20:S2, pages 257-265.
Crossref
Crossref
David Coghill. (2011) Pragmatic measures in paediatric psychopharmacology — Are we getting it right?. European Neuropsychopharmacology 21:8, pages 571-583.
Crossref
Crossref
David Coghill. (2011) Escalas y cuestionarios pragmáticos en psicofarmacología pediátrica: ¿estamos haciendo lo correcto?. Psiquiatría Biológica 18:3, pages 105-116.
Crossref
Crossref
Vania Modesto-LoweLarisa Yelunina & Kawal Hanjan. (2011) Attention-Deficit/Hyperactivity Disorder: A Shift Toward Resilience?. Clinical Pediatrics 50:6, pages 518-524.
Crossref
Crossref
David Coghill. (2010) The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder. CNS Drugs 24:10, pages 843-866.
Crossref
Crossref
Thomas W. FrazierMargaret WeissPaul HodgkinsMichael J. ManosJeanne M. LandgrafChristopher Gibbins. (2010) Time Course and Predictors of Health-Related Quality of Life Improvement and Medication Satisfaction in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder Treated with the Methylphenidate Transdermal System. Journal of Child and Adolescent Psychopharmacology 20:5, pages 355-364.
Crossref
Crossref